Latest News
CV VC, a Swiss blockchain venture capitalist and incubator has not only extended its VC operations internationally to UAE and Africa but now offers fully compliant, bankable and transferable participation in an underlying portfolio of blockchain assets, delivering a balancing opportunity, high return potential and diversification.
The CV VC investment vehicles are Actively Managed Certificates (AMC) with a Swiss ISIN code allowing qualified global investors to securely engage in blockchain, a technology megatrend whose business value-add will reach a staggering USD3.1 trillion by 2030.
CV VC Blockchain T4T: The Blockchain Technology for Tomorrow allows qualified investors to participate in a
Fuse Venture Partners (Fuse), a European internet growth venture investor, has appointed Dipam Patel as a Principal, bringing over 10 years’ technology and investing experience to the firm.
Patel will work with the eight-person London-based European-focused team led by Managing Partner Spyro Korsanos as it looks to expand the firm’s investments into promising technology companies, focusing on Series B and C funding.
Having held roles with both GP Bullhound and Bryan Garnier, where he was involved in executing fundraising and M&A transactions generating over USD5 billion in aggregate value, Patel has significant technology, entrepreneurship and finance experience. He also
Bowmark Capital has further strengthened its investment, portfolio and origination teams with six new appointments.
Jessica Collins, Ben Culverwell, Jamal Lakhani and James Swainston join Bowmark as investment executives, while Sam Beesley and Jemma Litkie become members of the firm’s portfolio management and origination teams.
Collins was previously a senior consultant at Oliver Wyman where she focused on commercial due diligence and corporate strategy projects. Prior to that, she was an equities analyst at Fidelity International covering small cap companies.
Culverwell joins Bowmark from Houlihan Lokey where he was a member of the corporate finance team and worked
Schroders Capital has reached the EUR1 billion hard cap fundraising target for the Schroder Euro Enhanced Infrastructure Debt Fund II (JULIE II).
The fund, which is managed by Schroders Capital’s specialist infrastructure team, was launched in Q3 2020 and invests in European sub-investment grade infrastructure debt opportunities. The fundraising has been evenly split between Asian and European investors.
Today’s news follows shortly after an update in June which confirmed that more than EUR700 million had been raised. The fund is the second vintage of this strategy whose first fund (JULIE I) was launched in 2017, raising close to EUR350 million.
XPhyto Therapeutics Corp is to acquire 3a-diagnostics, Frickenhausen, Germany (3a), the company’s exclusive diagnostics development partner.
Pursuant to the definitive agreement, XPhyto will acquire all of the outstanding shares of 3a for EUR400,000, to be paid immediately, and EUR3.5 million, to be paid on closing, planned for on or around 31 October, 2021.
Hugh Rogers, CEO of XPhyto, says: “We have collaborated closely with the 3a-diagnostics team on several diagnostics products and have found them to be a highly innovative and focused partner. The successful development and recent launch of the 25-minute PCR test Covid-ID Lab is a great example
Willkie Farr & Gallagher (Wilkie) has appointed Dvir Oren as a partner in the firm’s Corporate & Financial Services Department, where he will be part of Willkie’s Private Equity Practice Group.
Oren, who was previously a partner at Kirkland & Ellis, will be based in the firm’s New York office.
“Dvir is an outstanding lawyer and strengthens Willkie’s premier private equity platform, further enhancing our deep bench of talented private equity attorneys practicing throughout the US and Europe,” says Jeffrey Poss, Co-Chair of the Private Equity Practice Group. “We are very pleased to welcome him to the Firm.”
Oren
Panakès Partners, an leading Italian venture capital firm focused on the Life Sciences sector, has held the first closing of its EUR150 million (USD180 million) Purple Fund, the firm’s second fund.
Panakès’ Purple Fund is currently the largest venture capital fund actively investing in Italian companies and the most significant fund dedicated wholly to the Life Sciences sector in Italy. The fund will invest in companies at the forefront of innovation, with a focus on Europe, and Italy in particular, which remains underserved in terms of Venture Capital funding.
The Purple Fund is the second venture capital fund dedicated to
Ntropy, a company aiming to remove the data barriers to understanding financial transactions, has closed a USD3.2 million seed round led by QED Investors, who has previously invested in fintech unicorns Nubank, Klarna, and Current.
Ntropy’s API enables businesses to convert raw data into contextualised and structured information understood by both man and machine.
January Ventures also participated in the investment round, along with founders and executives from Ramp, Square and Stripe. Ntropy has also added Eric Woodward, former Group President of Early Warnings, and Robert Phillps, author of Pricing Credit Products, and currently Director of pricing research at Amazon,
Keensight Capital, a private equity manager dedicated to pan-European Growth Buyout investments, is to sell, alongside the founder, its stake in ASTI, a global autonomous mobile robotics (AMR) manufacturer, to ABB.
Founded in 1982, ASTI supports one of Europe’s largest installed fleets of Autonomous Mobile Robots (AMRs) and has a broad customer base in automotive, logistics, food & beverage, and pharmaceutical in 20 countries worldwide. Since 2015, the company has enjoyed ~30 per cent growth on an annual basis and is targeting approximately USD50 million in orders in 2021. ASTI employs over 300 people in Spain, France and Germany.
ASTI’s
The majority (62 per cent) of GPs have declined to invest in a company due to ESG or ethical considerations in 2021, according to Investec’s annual GP Trends survey. Last year, this figure stood at 55 per cent, showing the continued and growing importance of ESG to GPs.
Investec’s research, which analyses the views of 219 private equity professionals around the world, shows that GPs’ focus on ESG varies considerably according to factors such as seniority within their firms, gender, and the size and type of fund.
ESG considerations have ‘significantly contributed’ to the decision not to invest in a
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
